Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

IPSC - Century Therapeutics Inc

IEX Last Trade
1.76
0.030   1.705%

Share volume: 373,313
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$1.73
0.03
1.73%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
13%
Profitability 0%
Dept financing 12%
Liquidity 75%
Performance 10%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.68%
1 Month
-22.81%
3 Months
-42.86%
6 Months
-49.28%
1 Year
-27.87%
2 Year
-82.22%
Key data
Stock price
$1.76
P/E Ratio 
-1.13
DAY RANGE
$1.66 - N/A
EPS 
-$2.04
52 WEEK RANGE
$1.28 - $5.51
52 WEEK CHANGE
-$0.29
MARKET CAP 
149.100 M
YIELD 
N/A
SHARES OUTSTANDING 
84.716 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.62
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$386,930
AVERAGE 30 VOLUME 
$353,823
Company detail
CEO: Lalo Flores
Region: US
Website: https://www.centurytx.com/
Employees: 102
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Century Therapeutics, Inc. specializes in adult stem cells to develop curative cell therapy products for cancer that overcome the limitations of first generation cell therapies as well as provides testing and research services.

Recent news